In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Gritstone Bio Inc (NASDAQ: GRTS) closed the day trading at $0.74 down -0.95% from the previous closing price of $0.74. In other words, the price has decreased by -$0.95 from its previous closing price. On the day, 1.53 million shares were traded. GRTS stock price reached its highest trading level at $0.775 during the session, while it also had its lowest trading level at $0.7088.
Ratios:
For a better understanding of GRTS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.20. In the meantime, Its Debt-to-Equity ratio is 2.02 whereas as Long-Term Debt/Eq ratio is at 1.89.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on February 28, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $4.
On March 28, 2023, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $8.B. Riley Securities initiated its Buy rating on March 28, 2023, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 23 ’23 when Economides Vassiliki bought 12,000 shares for $1.90 per share. The transaction valued at 22,829 led to the insider holds 214,058 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRTS now has a Market Capitalization of 78373504 and an Enterprise Value of 97736120. For the stock, the TTM Price-to-Sale (P/S) ratio is 58.93 while its Price-to-Book (P/B) ratio in mrq is 1.39. Its current Enterprise Value per Revenue stands at 5.98 whereas that against EBITDA is -0.74.
Stock Price History:
Over the past 52 weeks, GRTS has reached a high of $3.33, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is -63.47%, while the 200-Day Moving Average is calculated to be -62.06%.
Shares Statistics:
Over the past 3-months, GRTS traded about 2.88M shares per day on average, while over the past 10 days, GRTS traded about 3684710 shares per day. A total of 97.59M shares are outstanding, with a floating share count of 97.27M. Insiders hold about 8.58% of the company’s shares, while institutions hold 35.48% stake in the company. Shares short for GRTS as of 1711584000 were 9117240 with a Short Ratio of 3.17, compared to 1709164800 on 8222945. Therefore, it implies a Short% of Shares Outstanding of 9117240 and a Short% of Float of 10.4899995.
Earnings Estimates
Currently, Tema Cardiovascular and Metabol analysts are dedicated to thoroughly evaluating and rating the performance of Gritstone Bio Inc (GRTS) in the stock market.The consensus estimate for the next quarter is $0.74, with high estimates of $225.34 and low estimates of $1.28.
